Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs
November 14, 2022 YPrime

Adoption of decentralized clinical trials (DCTs) and other alternatives to conventional clinical trials have accelerated in the past two years. Drug development companies have increased their efforts to implement new tools to help educate patients about participating in clinical trials, obtain consent, collect patient data, monitor patient compliance, and manage clinical supplies. However, technology implementation does not always go smoothly without first taking user perspectives into account while developing these technologies and re-examining and adapting clinical trial strategies. This eBook contains several articles that provide needed insights for sponsors who are considering, selecting, or implementing digital technologies for patient-centric clinical trials.

eBOOK

Strategies and Technologies that Empower DCTs

November 2022

RELATED CONTENT

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

Effective Use of IRT in Decentralized and Hybrid Clinical Trials

The Importance of IRT in the Decentralized Clinical Trial Landscape

The Importance of IRT in the Decentralized Clinical Trial Landscape

Strategies and Technologies that Empower DCTs

Strategies and Technologies that Empower DCTs

LATEST CONTENT

eConsent? Yes. How About Flexible Consent?

eConsent? Yes. How About Flexible Consent?

Improving the Patient Experience Through User-Focused Design

Improving the Patient Experience Through User-Focused Design

A Better Approach To eConsent: Flexible Consent Through Enabling Technologies

A Better Approach To eConsent: Flexible Consent Through Enabling Technologies